The power of relationships: Implications for safer and unsafe practices among injection drug users

Drugs: Education, Prevention and Policy

Volumn 17, Issue 3, 2010, Pages 189-204

  Jackson, Lois ^a   Parker, Joanne ^a   Dykeman, Margaret ^b   Gahagan, Jacqueline ^a   Karabanow, Jeff ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952152341     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687630802378872     Document Type: Article

References (38)

1. Balian, R. (1998). Myth, truth and HIV, a user's perspective on the seroconversion rates, in Vancouver, Montreal and Ottawa. International Journal of Drug Policy, 9, 359-364.
2. Ball, A. L. (2007). HIV, injecting drug use and harm reduction: A public health response. Addiction, 102, 684-690.
3. Branigan, P., & Wellings, K. (1999). Acceptance of the harm minimization message in London clubs and underground system. Drugs: Education, Prevention and Policy, 6(3), 389-398.
4. Burris, S. (2006). Stigma and the law. The Lancet, 367, 529-531.
5. CCSA National Policy Working Group (1996). Harm reduction: Concepts and practice. Ottawa, ON: Canadian Centre on Substance Abuse.
6. Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (2005). The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science and Medicine, 61(3), 673-684.
7. Costenbader, E. C., Astone, N. M., & Latkin, C. A. (2006). The dynamics of injection drug users' personal networks and HIV risk behaviours. Addiction, 101, 1003-1013.
8. Côté, F., Godin, G., Mercure, S. A., Nöel, L., & Alary, M. (2006). Preventing HIV transmission among marginalized injection drug users: New insights from a Québec City based research. International Journal of Drug Policy, 17, 411-417.
9. Day, C., Conroy, E., Lowe, J., Page, J., & Dolan, K. (2006). Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health, 14, 120-125.
10. Eaves, C. S. (2004). Heroin use among female adolescents: The role of partner influence in path of initiation and route of administration. The American Journal of Drug and Alcohol Abuse, 30(1), 21-38.
11. Emmanuelli, J., & Desenclos, J. C. (2005). Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction, 100, 1690-1700.
12. Erickson, P. G., Riley, D. M., Cheung, Y. W., & O'Hare, P. A. (Eds.) (1997). Harm Reduction: A New Direction for Drug Policies and Programs. Toronto, ON: University of Toronto Press Incorporated.
13. Ezard, N. (2001). Public health, human rights and the harm reduction paradigm: From risk reduction to vulnerability reduction. International Journal of Drug Policy, 12, 207-209.
14. Fischer, B., Kalousek, K., Rehm, J., Powis, J., Krajden, M., & Reimer, J. (2006). Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan? Canadian Journal of Public Health, 97(6), 485-488.
15. Fraser, S. (2004). 'It's your life!': Injecting drug users, individual responsibility and hepatitis C prevention. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 8(2), 199-221.
16. Gogineni, A., Stein, M. D., & Friedmann, P. D. (2001). Social relationships and intravenous drug use among methadone maintenance patients. Drug and Alcohol Dependence, 64(1), 47-53.
17. Hwang, S. (2007). Science and ideology. Open Medicine, 1(2), E99-101.
18. Jackson, L., Bailey, D., Fraser, J., Johnson, K., Currie, A., & Babineau, D. (2002). Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia: An explanatory look at community and interpersonal influences. Canadian Journal of Public Health, 93(3), 219-222.
19. Keane, H. (2003). Critiques of harm reduction, morality and the promise of human rights. International Journal of Drug Policy, 14, 227-232.
20. Levy, J. A., & Anderson, T. (2005). The drug career of the older injector. Addiction Research and Theory, 13(3), 245-258.
21. Lovell, A. M. (2002). Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Social Science & Medicine, 55(5), 803-821.
22. Mangham, C. (2001). Harm reduction and illegal drugs: The real debate. Canadian Journal of Public Health, 92(3), 204-205.
23. Mateu-Gelabert, P., Treloar, C., AgullóCalatayud, V., Sandoval, M., Valderrama Zurián, J. C., Maher, L., et al. (2007). How can hepatitis C be prevented in the long term? International Journal of Drug Policy, 18, 338-340.
24. Miller, P. G. (2001). A critical review of the harm minimization ideology in Australia. Critical Public Health, 11(2), 167-178.
25. Moore, D., & Fraser, S. (2006). Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine, 62, 3035-3047.
26. Neaigus, A., Friedman, S., Curtis, R., Des Jarlais, D., Gurst, R., Jose, B., et al. (1993). The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Social Science & Medicine, 38(1), 67-78.
27. Nelles, B. (2005). Comment on 'What are drug users looking for when they contact drug services: Abstinence or harm reduction?' by Neil McKeganey, Zoe Morris, Joanne Neal, & Michele Robertson. Drugs: Education, Prevention and Policy, 12(4), 255-256.
28. Public Health Agency of Canada (PHAC) (2006). Environmental scan of injection drug user, related infectious diseases, high-risk behaviours, and relevant programming in Atlantic Canada. Halifax, NS: Public Health Agency of Canada.
29. Rhodes, T. (2002). The 'risk environment': A framework for understanding and reducing drugrelated harm. International Journal of Drug Policy, 13, 85-94.
30. Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., Hickman, M., et al. (2006). For debate: Public injection and the need for 'safer environment interventions' in the reduction of drugrelated harm. Addiction, 101(10), 1384-1393.
31. Roe, G. (2005). Harm reduction as paradigm: Is better than bad good enough? The origins of harm reduction. Critical Public Health, 15(3), 243-250.
32. Small, W., Kain, S., LaLiberte, N., Schechter, M., O'Shaughnessy, M. V., & Spittal, P. M. (2005). Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use & Misuse, 40, 831-843.
33. Smythe, B. P., Barry, J., & Keenan, E. (2001). Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction, 96, 717-727.
34. Statistics Canada. (2007). Population and dwelling count highlight tables, 2006 census. (Available from: http://www12.statcan.ca/english/census06/ data/popdwell/Tables.cfm).
35. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory. Thousand Oaks, CA: Sage.
36. Watters, J. K., & Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36(4), 416-430.
37. Weeks, M. R., Clair, S., Borgatti, S. P., Radda, K., & Schensul, J. J. (2002). Social networks of drug users in high-risk sites: Finding the connections. AIDS and Behavior, 6(2), 193-206.
38. Wood, E., Tyndall, M., Montaner, J., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injection facility. Canadian Medical Association Journal, 175(11), 1399-1404 (Pubitemid 44876560)